About Parexel
Parexel is a company based in Waltham (United States) founded in 1983 was acquired by EQT in July 2021. Parexel has completed 14 acquisitions, including 3ClinicalResearch, Atlas Medical Services and California Clinical Trials. Parexel operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and PRA Health Sciences, among others.
- Headquarter Waltham, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
EQT
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
3ClinicalResearch
& 13 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Parexel
Unlock access to complete
Software Development Team
152 people
Leadership Team
144 people
Senior Team
97 people
Operations Team
94 people
Clinical Team
41 people
Finance and Accounting
40 people
Data Analysis and Operations Team
40 people
Principal Team
25 people
Unlock access to complete
Funding Insights of Parexel
Detailed funding history for Parexel
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Parexel
Parexel has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include EQT, Goldman Sachs Asset Management and Pamplona Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
Private equity investment firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Global asset management and investment solutions are provided.
|
Locked | Locked | Locked |
Investor details for Parexel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Parexel
Parexel has strategically engaged in corporate development activities, having acquired 14 companies. Notable acquisitions include 3ClinicalResearch, Atlas Medical Services and California Clinical Trials.
Investment portfolio details for Parexel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Offers software solutions for pharmacovigilance, clinical research, and data analytics.
|
Locked | Locked | 2014 | Locked | |
|
Cloud-based patient population and health management is offered to providers.
|
Locked | Locked | 2011 | Locked | |
|
Specialized CRO services are provided to pharma and biotech companies.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Parexel
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Parexel
Detailed financials for Parexel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Parexel Comparisons
Peer comparison for Parexel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Parexel
Parexel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and PRA Health Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Parexel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Parexel
Complete news archive for Parexel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parexel
Parexel was founded in 1983.
Parexel is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Peyton Howell is the current CEO of Parexel.
Parexel International was founded in 1983 and is headquartered in Waltham, United States. Operations are conducted as a clinical research organization in the biopharmaceutical sector, with services encompassing clinical trials across phases I-IV, consulting on regulatory compliance and product development, informatics for data management, and access solutions for market entry and drug safety. Presence is maintained in 51 countries, supporting development of pharmaceuticals, biologics, medical devices, and biosimilars.
Parexel's top competitors include Emmes, Syneos Health and ClinChoice.
Parexel has made 14 acquisitions, including 3ClinicalResearch, Atlas Medical Services, and California Clinical Trials.
Parexel has 3 investors. Key investors include EQT, Goldman Sachs Asset Management, and Pamplona Capital Management.